Nrc Health annual ebitda margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2022
2023
2024
2025
Nrc Health EBITDA Margin Growth & History (NRC)
Nrc Health's ebitda margin was 21.99% for fiscal 2025.
View full Nrc Health company overviewNrc Health annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 21.99% | −6.82 pp |
| 2024 | 2024-12-31 | 28.81% | −2.11 pp |
| 2023 | 2023-12-31 | 30.92% | −1.61 pp |
| 2022 | 2022-12-31 | 32.53% | — |
| 2019 | 2019-12-31 | 37.95% | +3.92 pp |
| 2018 | 2018-12-31 | 34.04% | +1.03 pp |
| 2017 | 2017-12-31 | 33.01% | +0.63 pp |
| 2016 | 2016-12-31 | 32.38% | +2.53 pp |
| 2015 | 2015-12-31 | 29.86% | −2.62 pp |
| 2014 | 2014-12-31 | 32.48% | +1.66 pp |
| 2013 | 2013-12-31 | 30.82% | −0.90 pp |
| 2012 | 2012-12-31 | 31.73% | +0.31 pp |
| 2011 | 2011-12-31 | 31.41% | +2.14 pp |
| 2010 | 2010-12-31 | 29.28% | −1.11 pp |
| 2009 | 2009-12-31 | 30.38% | — |
Nrc Health quarterly ebitda margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −3.16% | −12.94 pp |
| Q1 2026 | 2026-03-31 | 22.23% | −7.98 pp |
| Q4 2025 | 2025-12-31 | 19.36% | −10.73 pp |
| Q3 2025 | 2025-09-30 | 28.70% | +2.11 pp |
| Q2 2025 | 2025-06-30 | 9.78% | −19.85 pp |
| Q1 2025 | 2025-03-31 | 30.22% | +1.31 pp |
| Q4 2024 | 2024-12-31 | 30.09% | −4.48 pp |
| Q3 2024 | 2024-09-30 | 26.59% | −3.74 pp |
| Q2 2024 | 2024-06-30 | 29.63% | −0.47 pp |
| Q1 2024 | 2024-03-31 | 28.90% | +0.36 pp |
| Q4 2023 | 2023-12-31 | 34.57% | — |
| Q3 2023 | 2023-09-30 | 30.33% | −2.58 pp |
| Q2 2023 | 2023-06-30 | 30.10% | −4.18 pp |
| Q1 2023 | 2023-03-31 | 28.54% | −5.31 pp |
| Q3 2022 | 2022-09-30 | 32.91% | — |
| Q2 2022 | 2022-06-30 | 34.29% | — |
| Q1 2022 | 2022-03-31 | 33.85% | — |
| Q3 2020 | 2020-09-30 | 41.43% | +5.54 pp |
| Q2 2020 | 2020-06-30 | 34.27% | −2.62 pp |
| Q1 2020 | 2020-03-31 | 37.11% | −1.39 pp |
| Q4 2019 | 2019-12-31 | 40.51% | +5.06 pp |
| Q3 2019 | 2019-09-30 | 35.88% | +0.72 pp |
| Q2 2019 | 2019-06-30 | 36.89% | +4.48 pp |
| Q1 2019 | 2019-03-31 | 38.50% | +5.48 pp |
| Q4 2018 | 2018-12-31 | 35.45% | +2.44 pp |
| Q3 2018 | 2018-09-30 | 35.16% | +6.65 pp |
| Q2 2018 | 2018-06-30 | 32.41% | −1.32 pp |
| Q1 2018 | 2018-03-31 | 33.02% | −3.61 pp |
| Q4 2017 | 2017-12-31 | 33.01% | −1.93 pp |
| Q3 2017 | 2017-09-30 | 28.51% | −2.66 pp |
| Q2 2017 | 2017-06-30 | 33.73% | +2.67 pp |
| Q1 2017 | 2017-03-31 | 36.63% | +4.43 pp |
| Q4 2016 | 2016-12-31 | 34.94% | +1.92 pp |
| Q3 2016 | 2016-09-30 | 31.17% | +0.99 pp |
| Q2 2016 | 2016-06-30 | 31.06% | +0.86 pp |
| Q1 2016 | 2016-03-31 | 32.20% | +6.15 pp |
| Q4 2015 | 2015-12-31 | 33.02% | +3.52 pp |
| Q3 2015 | 2015-09-30 | 30.18% | −4.06 pp |
| Q2 2015 | 2015-06-30 | 30.20% | +0.02 pp |
| Q1 2015 | 2015-03-31 | 26.05% | −9.81 pp |
| Q4 2014 | 2014-12-31 | 29.51% | −0.90 pp |
| Q3 2014 | 2014-09-30 | 34.24% | +3.28 pp |
| Q2 2014 | 2014-06-30 | 30.18% | +1.26 pp |
| Q1 2014 | 2014-03-31 | 35.86% | +3.07 pp |
| Q4 2013 | 2013-12-31 | 30.41% | −0.81 pp |
| Q3 2013 | 2013-09-30 | 30.95% | −0.82 pp |
| Q2 2013 | 2013-06-30 | 28.92% | −2.24 pp |
| Q1 2013 | 2013-03-31 | 32.79% | +0.10 pp |
| Q4 2012 | 2012-12-31 | 31.22% | −1.67 pp |
| Q3 2012 | 2012-09-30 | 31.78% | +2.09 pp |
| Q2 2012 | 2012-06-30 | 31.17% | +3.51 pp |
| Q1 2012 | 2012-03-31 | 32.69% | −2.39 pp |
| Q4 2011 | 2011-12-31 | 32.89% | — |
| Q3 2011 | 2011-09-30 | 29.68% | +0.21 pp |
| Q2 2011 | 2011-06-30 | 27.66% | +1.37 pp |
| Q1 2011 | 2011-03-31 | 35.08% | — |
| Q3 2010 | 2010-09-30 | 29.48% | — |
| Q2 2010 | 2010-06-30 | 26.29% | — |
Nrc Health ebitda margin trends
Between the periods ended 2009-12-31 and 2025-12-31, Nrc Health's ebitda margin decreased from 30.38% to 21.99%, a change of −8.39 percentage points. The latest reported quarter, Q2 2026, shows −3.16%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nrc Health source filings ↗